Evolus EOLS
NASDAQ EOLS
$6.81 -0.17 (-2.44%)
At close: Nov 10, 2026 · 4:00 PM EST

Evolus (EOLS) Shares Repurchased (2018)

Updated

Evolus (EOLS) recorded Shares Repurchased of $686,000 in Q1 2018.

Analysis

Evolus (EOLS) Shares Repurchased (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 377.00 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 1.71 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 5.00 Mn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 653.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.20 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 370.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Evolus 455.33 Mn 264.84 Mn 50.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 686,000.00
API Access

Evolus Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=EOLS&period=max&api_key=YOUR_API_KEY